Chunjie Yu

727 total citations
18 papers, 511 citations indexed

About

Chunjie Yu is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Chunjie Yu has authored 18 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Chunjie Yu's work include RNA modifications and cancer (6 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer-related molecular mechanisms research (3 papers). Chunjie Yu is often cited by papers focused on RNA modifications and cancer (6 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer-related molecular mechanisms research (3 papers). Chunjie Yu collaborates with scholars based in China and United States. Chunjie Yu's co-authors include Zhijian Qian, Fang Yu, Chuan He, Jiangbo Wei, Xiaolong Cui, Lizi Wu, Jörg Bungert, Wei Ni, Yue Sheng and Yong Huang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Chunjie Yu

18 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunjie Yu China 10 435 175 54 50 45 18 511
Yuanfei Shi China 11 375 0.9× 160 0.9× 53 1.0× 97 1.9× 41 0.9× 26 488
Shuhui Si China 10 444 1.0× 220 1.3× 12 0.2× 79 1.6× 43 1.0× 20 565
Omprakash Shriwas India 9 370 0.9× 151 0.9× 12 0.2× 140 2.8× 25 0.6× 12 477
Yong-Sheng Tu China 8 185 0.4× 137 0.8× 12 0.2× 37 0.7× 27 0.6× 17 311
Jia Gu China 12 184 0.4× 136 0.8× 63 1.2× 116 2.3× 11 0.2× 33 428
Mohamed A. Elkady Egypt 13 355 0.8× 330 1.9× 8 0.1× 70 1.4× 19 0.4× 25 568
Lichong Yan China 7 345 0.8× 218 1.2× 8 0.1× 25 0.5× 16 0.4× 9 401
Jung-Won Lee South Korea 9 265 0.6× 56 0.3× 43 0.8× 123 2.5× 8 0.2× 24 405
Huiling Zhou China 12 292 0.7× 99 0.6× 14 0.3× 86 1.7× 10 0.2× 22 375

Countries citing papers authored by Chunjie Yu

Since Specialization
Citations

This map shows the geographic impact of Chunjie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunjie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunjie Yu more than expected).

Fields of papers citing papers by Chunjie Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunjie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunjie Yu. The network helps show where Chunjie Yu may publish in the future.

Co-authorship network of co-authors of Chunjie Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunjie Yu. A scholar is included among the top collaborators of Chunjie Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunjie Yu. Chunjie Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yu, Fang, Shikan Zheng, Chunjie Yu, et al.. (2025). KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer. Journal of Clinical Investigation. 135(6). 5 indexed citations
2.
Wu, Qiong, Chunjie Yu, Fang Yu, et al.. (2024). Evi1 governs Kdm6b-mediated histone demethylation to regulate the Laptm4b-driven mTOR pathway in hematopoietic progenitor cells. Journal of Clinical Investigation. 134(24). 1 indexed citations
3.
Nar, Rukiye, Zhixing Wu, Yafang Li, et al.. (2024). Targeting METTL3 protein by proteolysis-targeting chimeras: A novel therapeutic approach for acute myeloid leukemia. Genes & Diseases. 12(4). 101452–101452. 6 indexed citations
4.
Yu, Fang, Allen Zhu, Shun Liu, et al.. (2023). RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity. Molecular Cell. 83(12). 2003–2019.e6. 31 indexed citations
5.
Yu, Chunjie, Yue Sheng, Fang Yu, et al.. (2023). Foxm1 haploinsufficiency drives clonal hematopoiesis and promotes a stress-related transition to hematologic malignancy in mice. Journal of Clinical Investigation. 133(15). 4 indexed citations
6.
Sun, Xiangyi, Guangen Zhou, Hongquan Jiang, et al.. (2022). Optimization of continuous drive friction welding process for AA6061-T6 circular pipe and conical head. Structures. 36. 1068–1079. 3 indexed citations
7.
Yu, Fang, Jiangbo Wei, Xiaolong Cui, et al.. (2021). Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic Acids Research. 49(10). 5779–5797. 169 indexed citations
8.
Yang, Ying, Yaping Chen, Xue Tian, et al.. (2021). Orthostatic hypotension following posterior spinal fusion surgeries for spinal deformity correction in adolescents: prevalence and risk factors. BMC Musculoskeletal Disorders. 22(1). 1039–1039. 1 indexed citations
9.
Wu, Qiong, Fang Yu, Yue Sheng, et al.. (2021). m<sup>6</sup>A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of <I>Foxm1</i> and <i>Asxl1</i> transcripts. Haematologica. 107(8). 1922–1927. 10 indexed citations
10.
Sheng, Yue, Jiangbo Wei, Fang Yu, et al.. (2021). A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex–mediated DNA replication. Blood. 138(26). 2838–2852. 108 indexed citations
11.
Sheng, Yue, Chunjie Yu, Yin Liu, et al.. (2020). FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML. Nature Communications. 11(1). 928–928. 67 indexed citations
12.
Sheng, Yue, Rui Ma, Chunjie Yu, et al.. (2020). Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice. Blood. 137(5). 610–623. 31 indexed citations
13.
Zhang, Yunyuan, Liping Li, Chunjie Yu, et al.. (2018). miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3. Scientific Reports. 8(1). 6519–6519. 15 indexed citations
14.
Liu, Ting, Zhenxing Zhang, Chunjie Yu, et al.. (2017). Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy‐mediated differentiation. British Journal of Pharmacology. 174(23). 4308–4328. 29 indexed citations
15.
Yu, Chunjie, Qiong Yang, Demin Wang, et al.. (2016). Tyrosine 625 plays a key role and cooperates with tyrosine 630 in MPL W515L-induced signaling and myeloproliferative neoplasms. Cell & Bioscience. 6(1). 34–34. 1 indexed citations
16.
Yu, Chunjie, Jiancheng Zeng, Zhenzhen Yan, et al.. (2016). Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest. Cell & Bioscience. 6(1). 20–20. 16 indexed citations
17.
Cai, Jinyang, Rui Gong, Fengjuan Yan, et al.. (2014). ZNF300 Knockdown Inhibits Forced Megakaryocytic Differentiation by Phorbol and Erythrocytic Differentiation by Arabinofuranosyl Cytidine in K562 Cells. PLoS ONE. 9(12). e114768–e114768. 11 indexed citations
18.
Wu, Fei, et al.. (2014). Offshore oil and gas platform decommissioning research. 1–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026